Diane Poster

University Hospital of Zurich — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index1.5kcitations18works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic and Kidney Cyst Diseases(15), Renal Diseases and Glomerulopathies(8), Biomedical Research and Pathophysiology(5), Pediatric Urology and Nephrology Studies(4), Parathyroid Disorders and Treatments(3)

Publications18 total

Urinary Biomarkers at Early ADPKD Disease Stage
PLoS ONE·2015· 36 citedOpen Access
Correction: Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
PLoS ONE·2013· 11 citedOpen Access
INFORMED CONSENT IN ADVANCE CARE PLANNING IN THE PALLIATIVE CARE SETTING: A DECISION AID LIBRARY FOR END OF LIFE CARE
BMJ Supportive & Palliative Care·2013· 1 citedOpen Access
Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
PLoS ONE·2013· 77 citedOpen Access
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study
Nephrology Dialysis Transplantation·2012· 226 citedOpen Access
Low-Dose Oral Sirolimus and the Risk of Menstrual-Cycle Disturbances and Ovarian Cysts: Analysis of the Randomized Controlled SUISSE ADPKD Trial
PLoS ONE·2012· 40 citedOpen Access
Growth of arachnoid cysts in patients with autosomal dominant polycystic kidney disease: serial imaging and clinical relevance
Clinical Kidney Journal·2012· 16 citedOpen Access
Ovarian Toxicity from Sirolimus
New England Journal of Medicine·2012· 34 citedOpen Access
Soluble Klotho and Autosomal Dominant Polycystic Kidney Disease
Clinical Journal of the American Society of Nephrology·2011· 76 citedOpen Access
Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate
Kidney International·2010· 84 citedOpen Access
Autosomal-dominante polyzystische Nierenerkrankung
Der Nephrologe·2010· 1 citedOpen Access
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
New England Journal of Medicine·2010· 554 citedOpen Access
Hydronephrosis in autosomal dominant polycystic kidney disease
Kidney International·2009· 2 cited
Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease
Nephrology Dialysis Transplantation·2009· 19 citedOpen Access
Kidney Function and Volume Progression in Unilateral Autosomal Dominant Polycystic Kidney Disease With Contralateral Renal Agenesis or Hypoplasia: A Case Series
American Journal of Kidney Diseases·2009· 14 cited
Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease
Kidney International·2009· 93 citedOpen Access
Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months
Kidney International·2008· 132 citedOpen Access
Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study
BMC Nephrology·2007· 56 citedOpen Access

Frequent Co-authors

Andreas L. Serra(17), Rudolf P. Wüthrich(15), Andreas D. Kistler(12), Fabienne Krauer(11), Dominik Weishaupt(5), Ivana Pavik(5), Oliver Senn(4), Jim Young(3), Katharina Rentsch(3), Katharina Spanaus(3), Philippe Jaeger(3), Harald Mischak(3), Gustav Andreisek(3), Shagun Raina(2), Paulus Kristanto(2), Lena Ebner(2), Carsten A. Wagner(2), Katja Petzold(2), Justyna Siwy(2), Vicente E. Torres(2)